Physician profile
Eric Bradfield
NPI 1083924583
$920.06
in general payments reported to CMS, 2019-2025
11 companies · $557 in 2025
The $557 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $363 · 2025: $557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $920.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $920.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $263.56 | 2024-2025 | Jardiance |
| Pfizer INC. | $129.21 | 2024-2025 | |
| Organogenesis INC. | $104.01 | 2024 | Puraply Wound Matrix |
| Novartis Pharmaceuticals Corporation | $101.90 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $99.82 | 2024-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $80.69 | 2024-2025 | Farxiga, Airsupra |
| Scpharmaceuticals INC. | $63.54 | 2025 | |
| Aimmune Therapeutics, INC. | $32.88 | 2025 | Zenpep |
| Glaxosmithkline, LLC. | $17.03 | 2025 | Trelegy Ellipta |
| Novo Nordisk INC | $16.31 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.11 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Bradfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.